An observational study in Headache, Migraine, sponsored by Anne Ducros. Status unknown. Open to participants aged 18 Years to 100 Years. Per ClinicalTrials.gov, last updated 2019-05-30.
Sponsored by Anne Ducros · Observational
Description of modalities concerning the patient care of headaches sensible to indometacine.
Description of clinical profile, treatment of crisis and background treatment
1,528 studies on the registry are indexed under Migraine Disorders; 299 are open to participants now.
This study's planned enrollment of 100 is below the median of 130 across 299 observational studies indexed under Migraine Disorders.
Browse Migraine Disorders studies →This is the only study on the registry with Anne Ducros as lead sponsor.
Counted across the registry records on this site, refreshed daily.
Patient sufffuring from headaches or migraine and who is receiving Indometacine
Exclusion Criteria:
patient who are taken indomatacin for headaches and migraine
Description of headaches sensible to indometacine
Description of the clinical cases with headaches sensible to indometacine according to the type of headaches.
Time frame: 24 monthes
No study locations are listed for this record.
This study is status unknown, as verified in May 2019. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.